Corton Capital’s Bio-Techne TECH Stock Holding History

Corton Capital’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,992	Closed	-$286K	–	660
2024 Q2	$286K	Buy	+3,992	New	+$294K	0.15%	214
2022 Q2	–	Sell	-2,060	Closed	-$223K	–	508
2022 Q1	$223K	Buy	+2,060	New	+$213K	0.1%	329

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Corton Capital's TECH Position: Q3 2024 in Review

Corton Capital sold out of Bio-Techne (TECH) in Q3 2024, closing a stake of 3,992 shares — an estimated $286K sold.

Corton Capital first reported a position in TECH in Q1 2022 and held it in 2 quarters. The position peaked at $286K in Q2 2024. 562 funds tracked by Wall St. Rank hold TECH as of Q3 2024.

Corton Capital reported no remaining Bio-Techne position as of Q3 2024 after selling out during the quarter.
Corton Capital sold 3,992 Bio-Techne shares in Q3 2024, an estimated $286K.
Corton Capital first reported a position in Bio-Techne in Q1 2022 and held it in 2 quarters.
Corton Capital's Bio-Techne position peaked at $286K in Q2 2024.
562 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2024.

Based on Corton Capital's 13F filing for Q3 2024, filed 14 Nov 2024.